Trade Gilead ^GILD

Fifth Third Bancorp Increases Position in Gilead Sciences, Inc. $GILD

Danske Bank A S Sells 45,529 Shares of Gilead Sciences, Inc. $GILD

Keybank National Association OH Has $14.15 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax

Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 10,000 Shares - Zolmax

Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?

Gilead Sciences Annual Meeting: Directors, Pay Win Big; Pipeline Launches and Acquisitions Highlighted - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by Verity Asset Management Inc.

Gilead Sciences, Inc. $GILD Position Trimmed by State of New Jersey Common Pension Fund D

FY2026 EPS Estimates for Gilead Sciences Reduced by Analyst

Is It Time To Revisit Gilead Sciences (GILD) After Recent Share Price Pullback

Gilead Sciences (NASDAQ:GILD) CEO Sells $1,291,600.00 in Stock

GILD: Gilead's New HIV Treatment Gains FDA Acceptance

How Investors May Respond To Kymera Therapeutics (KYMR) FDA Fast Track Win And Gilead Trial Expansion

Morgan Stanley Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Moderate Buy" by Analysts

Gilead Sciences (GILD) Closes $7.8B Arcellx Buyout - What Investors Need to Know

Gilead Sciences Completes Acquisition of Arcellx (ACLX)

Merck Broadens Growth Story With Heart Campaign And New Drug Approvals

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel | Morningstar

Mitsubishi UFJ Trust & Banking Corp Decreases Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences reports new GTPase KRAS G12D inhibitors and degraders | BioWorld

M&T Bank Corp Sells 147,548 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Set to Acquire Arcellx

Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial

Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock

Top Pharmaceutical Stocks To Keep An Eye On - April 26th - Daily Political

Concurrent Investment Advisors LLC Grows Position in Gilead Sciences, Inc. $GILD

AEGON ASSET MANAGEMENT UK Plc Reduces Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Polaris Capital Management LLC

Arcus Biosciences (RCUS) Is Up 5.2% After Lung Trial Futility Results And Gilead Option Shift

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Calamos Advisors LLC Sells 9,121 Shares of Gilead Sciences, Inc. $GILD

Gilead Refines Arcus Ties As Oncology Focus And Valuation Gap Draw Attention

2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down

NBC Securities Inc. Acquires 10,296 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD is Kerusso Capital Management LLC's 6th Largest Position

Gilead Sciences, Inc. $GILD Stake Boosted by China Universal Asset Management Co. Ltd.

Kerusso Capital Management LLC Grows Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Ends Losing Streak with 0.56% Gain

Has Gilead Sciences (GILD) Pulled Back Enough To Revisit Its Valuation Story?

Gilead Sciences, Inc. $GILD Holdings Decreased by Ruffer LLP

West Michigan Advisors LLC Purchases 4,173 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness And Long Term Gains

KLP Kapitalforvaltning AS Trims Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Merck (MRK) Receives FDA Approval for Idvynso, a New HIV Treatment

Zacks Research Predicts Lower Earnings for Gilead Sciences

Ticino Wealth Buys Shares of 7,568 Gilead Sciences, Inc. $GILD - Daily Political

Population pharmacokinetics of tenofovir alafenamide delivered via an annual subdermal implant in South African women

Zurcher Kantonalbank Zurich Cantonalbank Purchases 19,741 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Stake Lowered by Miller Howard Investments Inc. NY

Gilead Sciences, Inc. $GILD Shares Sold by Miller Howard Investments Inc. NY - Stock Observer

Gilead Deepens Oncology Reach And HIV Prevention With Arcellx And Lenacapavir

Gilead Sciences, Inc. $GILD Shares Acquired by AE Wealth Management LLC

Gilead Leans Further Into Oncology With Arcellx And Tubulis Deals

Gilead Sciences, Inc. $GILD Shares Bought by GF Fund Management CO. LTD.

Gilead Sciences, Inc. $GILD Position Raised by Asset Management One Co. Ltd.

The Goldman Sachs Group Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - Stock Observer

Citi Raises Gilead (GILD) Price Target Ahead of Q1 Biopharma Preview

How Investors Are Reacting To Gilead Sciences (GILD) Expanding No‑Profit Lenacapavir Access Globally

Jim Cramer on Gilead Sciences: "I'd Hold On to It"

GILD: Oncology Deals And HIV Franchise Will Support Future Earnings

Gilead Sciences (NASDAQ:GILD) Given New $130.00 Price Target at The Goldman Sachs Group

Morgan Stanley Adjusts Gilead Sciences, Inc. (GILD) Outlook Ahead of Q1 Earnings

Pharmaceutical Stocks To Follow Now - April 17th - Stock Observer

Mirae Asset Global Investments Co. Ltd. Grows Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares - Markets Daily

Farther Finance Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Stock Holdings Lowered by Assetmark Inc.

Mirae Asset Global Investments Co. Ltd. Raises Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences (NASDAQ:GILD) CFO Andrew Dickinson Sells 3,000 Shares of Stock - Stock Observer

Gilead Sciences patents new GTPase KRAS G12D inhibitors | BioWorld

Arcellx Inc. (ACLX) - Insider Monkey

Andrew Dickinson Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock

Insider Selling: Gilead Sciences (NASDAQ:GILD) Insider Sells $422,880.00 in Stock

Gauging Gilead Sciences (GILD) Valuation After Strong Multi‑Year Shareholder Returns

KBC Group NV Has $398.25 Million Stake in Gilead Sciences, Inc. $GILD

Zacks Research Expects Lower Earnings for Gilead Sciences

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $165.00 - Zolmax

Gilead's Lenacapavir Access Push And Pricing Protests Shape HIV Outlook

Gilead Sciences (GILD) to Release Quarterly Earnings on Thursday

Pursuit Wealth Management LLC Acquires Shares of 5,826 Gilead Sciences, Inc. $GILD - Daily Political

Lbp Am Sa Has $27.41 Million Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Cramer's lightning round: Nokia still has room to run

Bingham Private Wealth LLC Invests $1.42 Million in Gilead Sciences, Inc. $GILD

Zacks Research Predicts Weaker Earnings for Gilead Sciences - Daily Political

- Additional Commitment will Expand Access to Lenacapavir to

Is It Too Late To Consider Gilead Sciences (GILD) After Its Strong 1 Year Share Price Run?

Gilead Sciences, Inc. $GILD Shares Purchased by Patton Fund Management Inc. - Markets Daily

Patton Fund Management Inc. Grows Position in Gilead Sciences, Inc. $GILD

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

The Week Ahead: ISM services, SMCI

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Earnings season climax

Week ahead: RBA poised to hike?

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk